Memorial Sloan-Kettering Cancer Center (MSKCC) is a freestanding institution, founded as the New York Cancer Hospital in 1884 and now located in the upper east side of New York city, adjacent to the health sciences campuses of Cornell Medical College and Rockefeller University. The Center's mission is the progressive control and cure of cancer through programs of research, patient care, and education. MSKCC is dedicated to the study of cancer through a defined spectrum of laboratory research, an interactive program spanning basic and clinical science, a strong capability for basic-to-clinic technology transfer, a structured program of clinical cancer research, state-of-the-art clinical programs, including in-patient and extensive out-patient clinical care, community care focused on early diagnosis and specific cancers and a strategically selected set of priorities in cancer control and prevention that addresses issues of both local and national importance. The research activities of MSKCC are administratively organized in seven research programs: Molecular Biology, Cell Biology & Genetics, Cellular Biochemistry & Biophysics, Immunology, Molecular Pharmacology & Therapeutics, Clinical Research, and Cancer Control & Prevention. One of these, Cellular Biochemistry & Biophysics, is a """"""""developing program"""""""" according to the CCSG guidelines. These Programs are supported by 17 CCSG-supported Core Facilities as well as others supported entirely by institutional resources. The Core Facilities for which CCSG support is requested are: Preparative Synthesis, Nuclear Magnetic Resonance, Pharmacology Analytical Facility, General Animal Facility, Animal Health Service, Transgenic Mouse Facility, Glassware Washing, Core Media Preparation, Flow Cytometry, Cyclotron, Microchemistry, Cytogenetics, Human Tumor Procurement, Biosafety, Biostatistics, Clinical Research Support, and the Research Pharmacy. Funds are also requested for Planning & Evaluation and for Development.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA008748-29
Application #
2084603
Study Section
Cancer Center Support Review Committee (CCS)
Project Start
1977-01-01
Project End
1997-12-31
Budget Start
1994-03-22
Budget End
1994-12-31
Support Year
29
Fiscal Year
1994
Total Cost
Indirect Cost
Name
Sloan-Kettering Institute for Cancer Research
Department
Type
DUNS #
064931884
City
New York
State
NY
Country
United States
Zip Code
10065
Pulitzer, Melissa; Geller, Shamir; Kumar, Erica et al. (2018) T-cell receptor-? expression and ??+ T-cell infiltrates in primary cutaneous ?? T-cell lymphoma and other cutaneous T-cell lymphoproliferative disorders. Histopathology 73:653-662
Geller, Shamir; Dickson, Mark A; Busam, Klaus J et al. (2018) Kaposi's Sarcoma After Autologous Stem-Cell Transplantation and Rituximab Treatment. J Oncol Pract 14:565-568
Brand, Christian; Sadique, Ahmad; Houghton, Jacob L et al. (2018) Leveraging PET to image folate receptor ? therapy of an antibody-drug conjugate. EJNMMI Res 8:87
Jiang, Jue; Hu, Yu-Chi; Tyagi, Neelam et al. (2018) Tumor-aware, Adversarial Domain Adaptation from CT to MRI for Lung Cancer Segmentation. Med Image Comput Comput Assist Interv 11071:777-785
Cifani, Paolo; Dhabaria, Avantika; Chen, Zining et al. (2018) ProteomeGenerator: A Framework for Comprehensive Proteomics Based on de Novo Transcriptome Assembly and High-Accuracy Peptide Mass Spectral Matching. J Proteome Res 17:3681-3692
Ito, Kimiteru; Schöder, Heiko; Teng, Rebecca et al. (2018) Prognostic value of baseline metabolic tumor volume measured on 18F-fluorodeoxyglucose positron emission tomography/computed tomography in melanoma patients treated with ipilimumab therapy. Eur J Nucl Med Mol Imaging :
Shah, Gunjan L; Scordo, Michael; Kosuri, Satyajit et al. (2018) Impact of Toxicity on Survival for Older Adult Patients after CD34+ Selected Allogeneic Hematopoietic Stem Cell Transplantation. Biol Blood Marrow Transplant 24:142-149
Abraham, Ann; Zhang, Alysandra J; Ahn, Rosa et al. (2018) Media Content Analysis of Marijuana's Health Effects in News Coverage. J Gen Intern Med 33:1438-1440
Maiga, Amelia W; Deppen, Stephen A; Mercaldo, Sarah Fletcher et al. (2018) Assessment of Fluorodeoxyglucose F18-Labeled Positron Emission Tomography for Diagnosis of High-Risk Lung Nodules. JAMA Surg 153:329-334
Raj, Nitya; Reidy-Lagunes, Diane (2018) The Role of 68Ga-DOTATATE Positron Emission Tomography/Computed Tomography in Well-Differentiated Neuroendocrine Tumors: A Case-Based Approach Illustrates Potential Benefits and Challenges. Pancreas 47:1-5

Showing the most recent 10 out of 8799 publications